Repligen will acquire BioLife Solutions for $1.5 billion, merging two longtime providers of tools for cell and gene therapy and biopreservation. The deal values BioLife shares at $31 each and is slated to close in the fourth quarter pending approvals.
BioLife develops biopreservation products for cell and gene therapy.
Cell and gene therapies treat disease at the molecular level.
Tap a lens to see what this story means for you.
Liked this? The Brief brings you the whole day in tech, verified, every morning.
Two minutes, free forever. What's in The Brief →
See what’s happening right now
The Feed runs all day — short, verified briefs the moment they break.
Open the FeedFollow @thecircuitry_
Every story we publish, as it happens. No noise between.
Reader-supported
The Circuitry is a passion project I've always wanted to build, and I love the work behind it.
Running it costs real money. APIs, hosting, time. To keep improving the site and growing this into something useful for everyone, those costs have to be covered.
Any contribution is appreciated. If not, no pressure. Thanks for reading.
Bitcoin Magazine reports that Payward, parent of Kraken, signed a definitive agreement to buy Saldo Finance Oy and its banking subsidiary, securing an EU license spanning five markets. Closing is targeted for 2027 and would support deposit interest, loans, credit cards and banking-as-a-service products.
Stripe has finalized an agreement to acquire AI gateway startup OpenRouter for more than $7 billion according to Bloomberg. The deal values the company far above its $1.3 billion valuation from a May funding round and brings a platform with 8 million users and access to over 400 models into Stripe's portfolio.
Payward, the parent of Kraken, has acquired Bitnomial for up to $550 million in cash and stock. The deal provides a complete CFTC-regulated derivatives stack, enabling direct offering of regulated crypto products in the U.S. and following its earlier NinjaTrader purchase.
Nvidia is in early talks to acquire Reflection AI or invest more in the open-weight model startup, the Financial Times reported. Bloomberg reported talks on a bigger investment or computing deal, with no terms agreed. Nvidia has already invested $800 million, the FT said.
Google DeepMind, Meta, and Isomorphic Labs are investing $300 million in Biohub to build AI datasets for a virtual cell model. The funding is part of a $1.8 billion initiative that also includes contributions from the Department of Energy and National Institutes of Health.
